Don't sweat these discounts, they can't be beat.
Vacation Races has pivoted to Staycation Races. Somehow, it’s working.
Nasdaq Stock Exchange President Nelson Griggs joins Yahoo Finance’s Seana Smith to discuss market operations amid the coronavirus and the outlook on IPOs.
Let's raise a toast to May the 4th. Geeki Tikis' awesome Star Wars variant tiki mugs include exclusive mini-mugs. Muglets for everyone! The post Make a Toast with These STAR WARS May the 4th Tiki Mugs appeared first on Nerdist.
Get pumped. We've rounded up loads of awesomely discounted footwear, apparel, GPS watches, cycling gear and more just for you.
If you’re in love with tiki mugs and are a fan of everything Star Wars, you’ll love what I’m about to show you! Entertainment Earth has just added a gorgeous and quite gigantic 40oz. Jabba The Hutt tiki mug to its shop as well as a 45oz. Rancor version, and I…
Our website is based on Markdown content rendered with Hugo. Markdown content is in some cases knit from R Markdown, but with less functionality than if one rendered R Markdown to html as in the blogdown default. In particular, we cannot use the usual BibTex …
Get pumped. We've rounded up loads of awesomely discounted footwear, apparel, sunglasses, cycling gear and more just for you.
Get pumped. We've rounded up loads of awesomely discounted footwear, apparel, GPS watches, cycling gear and more just for you.
Read a comparison of BIB and LABU and a description of the characteristics and historical performance of these leveraged biotech ETFs.
With another week we have yet another installment of our product drops series. Leading the list is the release of Supreme's newest Spring/Summer 2020 offerings, along with the Week 3 release of Palace's Summer 2020 collection.Week 14 from Supreme takes a brea…
In honor of Star Wars Day and humongous tropical cocktails, these are the 40-ounce Jabba The Hutt and 45-ounce Rancor tiki mugs created by Geeki Tiki and available from Toynk. Either mug costs $75 and Jabba comes with a 2.5-ounce Bib Fortuna mini mug, and the…
Recently, Rapha released a summer-weight jersey, Polar revealed a new GPS watch, Wahoo updated its heart rate monitor and more.
Fact: Every Animal Crossing: New Horizons resident wants a killer art collection. Last week, Nintendo’s pastel capitalist vacation sim introduced its players to a new way to acquire great art: the scurrilous rube, Jolly Redd.Read more...
Broadly speaking, drug stocks have been some of the strongest performing names in the latter part of 2019.Since October 2019, the iShares NASDAQ Biotechnology ETF (NASDAQ:IBB) has rallied from a low of $96 to nearly $124. The SPDR S&P Biotech ETF (NYSE:XBI) exploded from $75 to a high of $98.79. Even ProShares Ultra NASDAQ Biotechnology (NASDAQ:BIB) popped from a low of $41 to a high of nearly $65.All despite concerns over potential changes to drug pricing policies with elections ahead.InvestorPlace - Stock Market News, Stock Advice & Trading Tips"While we get the sense that biotech investors are cautious into 2020 with the election and broader macro concerns, we believe that macro issues are unlikely to have material fundamental impact," says Credit Suisse's Evan Seigerman.Wedbush analysts argue, "The fundamentals of the sector look strong. Biotech surged in the third quarter, approvals from the Food & Drug Administration are coming through above the average annual rate, the valuation of large-cap biotechs are attractive, and there have been significant mergers and acquisitions in past years."Plus, one of the biggest catalysts for future growth are the millions of retiring baby boomers.We're also seeing new, innovative treatments for a myriad of issues. In addition, such stocks are recession-proof because folks will always require medical attention. * 10 2019 Winners That Will Be 2020 Losers Here are three of the top biotech stocks to watch in the New Year. Top Drug Stocks: Fate Therapeutics (FATE)After struggling out the gate, Fate Therapeutics (NASDAQ:FATE) exploded from a low of $14 to $20 a share after posting positive trial results from its natural kill (NK) cell product candidate.With regards to data from its natural killer (NK) cell product candidate, "Current patient- and donor-specific CAR T-cell immunotherapies recognize only one antigen and fail to address the significant risk of relapse due to antigen escape. FT596 is ground-breaking in that it is designed to be available off-the-shelf for timely patient access and to promote deeper and more durable responses by targeting multiple tumor-associated antigens," said Bob Valamehr, Ph.D., Chief Development Officer of Fate Therapeutics.The company's other natural cell killer was also found to kill off cancer in a patient with acute myeloid leukemia (AML). Wells Fargo recently upgraded the FATE stock to an overweight rating with a target of $24. Axsome Therapeutics (AXSM)Axsome Therapeutics (NASDAQ:AXSM) had an explosive year. Since January 2019, AXSM stock exploded from a low of $2.64 to a recent high of $105.55. All after a series of major announcements, throughout the year. In January, for example, AXSM noted that its lead drug candidate, AXS-05 met its primary endpoint in a Phase II trial for major depressive disorder.Two months later, AXSM won FDA Breakthrough Therapy for the drug. By April, the drug also achieved its primary endpoint for smoking cessation. By December, its AXS-12 drug met its primary endpoint in a Phase II trial targeting narcolepsy.Then just two weeks ago, the AXSM stock ramped higher on news of positive late-state results for AXS-05, as a treatment of major depressive disorder. * 10 Stocks That Every 30-Year-Old Should Buy and Hold Forever "Given the documented medical need for more potent MDD therapies, and the fact that a whopping 17 million American adults suffer from this condition every year, according to the National Institutes of Health, this experimental depression med has a clear path toward blockbuster status," noted Motley Fool contributor George Budwell. Pfizer (PFE)Last year wasn't kind to Pfizer (NYSE:PFE) or its shareholders. In late July, PFE plunged 21% on company plans to combine its blockbuster drug-selling unit with Mylan (NYSE:MYL), and announced it was cutting its sales and adjusted earnings forecast.However, with a strong drug portfolio, acquisitions, and an undervalued stock, PFE is attracting interest once again. The company also just raised its dividend by 5.6%, which brings the new quarterly dividend to 38 cents from 36 cents payable March 6, 2020 to shareholders as of Jan. 31.Plus, "the valuation on new Pfizer looks appealing, given management's expectation of 6% annualized sales growth through 2025, which could produce 10%-plus yearly gains in earnings per share. New Pfizer has important patent-protected drugs like Ibrance for breast cancer and the pneumonia vaccine Prevnar, plus a strong pipeline," notes Barron's contributor Andrew Bary.As of this writing, Ian Cooper did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 2019 Winners That Will Be 2020 Losers * 5-Year Returns for 5 Dow Jones Stocks Entering 2020 * 5 Semiconductor Stocks to Buy for Big Gains In 2020 The post 3 Top Drug Stocks to Own In 2020 appeared first on InvestorPlace.
Shares of biotech Inovio Pharmaceuticals Inc. fell more than 20% Friday, as analysts weighed in on the company’s latest earnings and RBC downgraded the stock on valuation grounds.
From Darth Vader’s actual codpiece to Bib Fortuna toothpaste, no one has a Star Wars collection like Steve Sansweet. And that’s an actual fact. His collection is considered the largest by the Guinness Book of World Records.Read more...
The post-rock vets also have a new career-spanning rarities comp out now and they're releasing their full score for the Vespertine restaurant in June. Continue reading…
Wanna be on top? For 24 straight seasons (sorry, cycles) hundreds of thousands of runway rookies very much did. Leggy natives of Joliet, Illinois and Grand Forks, North Dakota turned up...
Save big on shades, shoes, sweatshirts and more — we've compiled the very best athletic discounts of the week just for you.
Earlier this morning, Disney and Lucasfilm kicked off Star Wars Day (May the Fourth be with you) by announcing that Taika Waititi will be co-writing and directing a new Star Wars movie. But let’s get down to what this day is really about: merchandising. After…
Save big on shades, shoes, sweatshirts and more -- we've compiled the very best athletic discounts of the week just for you.
Paragraphasing Writing R Extensions, an R package is “directory of files which extend R”. These files have to follow a standard structure: you can’t store everything that suits your fancy in a tarball you submit to CRAN. In this post we shall go through what …
Don't sweat these discounts, they can't be beat.